VIP and idiopathic pulmonary fibrosis: This is a key point since NEP metabolizes a number of vasoactive peptides, such as endothelin-1, bradykinin, and vasoactive intestinal peptide (Campbell, 2003), yet it appears that it is primarily the enhancement of the cytoprotective effects of natriuretic peptides that underpins the efficacy of combination treatment in IPF.